Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 533

1.

Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer.

Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T.

EGEMS (Wash DC). 2018 Jun 1;6(1):13. doi: 10.5334/egems.234.

2.

Impact of Frailty on Outcomes in Acute Type A Aortic Dissection.

Gomibuchi T, Seto T, Komatsu M, Tanaka H, Ichimura H, Yamamoto T, Ohashi N, Wada Y, Okada K.

Ann Thorac Surg. 2018 Aug 4. pii: S0003-4975(18)31061-0. doi: 10.1016/j.athoracsur.2018.06.055. [Epub ahead of print]

PMID:
30086279
3.

Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging.

Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3011-3019. doi: 10.1167/iovs.17-23699.

4.
5.

Optical Detection of Macular Pigment Formation in Premature Infants.

Sasano H, Obana A, Sharifzadeh M, Bernstein PS, Okazaki S, Gohto Y, Seto T, Gellermann W.

Transl Vis Sci Technol. 2018 Jul 9;7(4):3. doi: 10.1167/tvst.7.4.3. eCollection 2018 Jul.

6.

Optic coherence tomography appearances of retinal astrocytic hamartoma and systemic features in tuberous sclerosis of Japanese patients.

Kato A, Obana A, Gohto Y, Seto T, Sasano H.

Eur J Ophthalmol. 2018 Jul 1:1120672118787441. doi: 10.1177/1120672118787441. [Epub ahead of print]

PMID:
29991284
7.

Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.

Murakami H, Nokihara H, Hayashi H, Seto T, Park K, Azuma K, Tsai CM, Yang JC, Nishio M, Kim SW, Kiura K, Inoue A, Takeda K, Kang JH, Nakagawa T, Takeda K, Akazawa R, Kaneko Y, Shimazaki M, Morita S, Fukuoka M, Nakagawa K.

Cancer Sci. 2018 Jul 4. doi: 10.1111/cas.13724. [Epub ahead of print]

8.

Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.

Hida T, Seto T, Horinouchi H, Maemondo M, Takeda M, Hotta K, Hirai F, Kim YH, Matsumoto S, Ito M, Ayukawa K, Tokushige K, Yonemura M, Mitsudomi T, Nishio M.

Cancer Sci. 2018 Jun 30. doi: 10.1111/cas.13721. [Epub ahead of print]

9.

The New Mode of Energy Transferring between Mn2+ and Eu2+ in Nitride Based Phosphor SrAlSi4N7 with Tunable Light and Excellent Thermal Stability.

Ding J, Seto T, Wang Y, Cao Y, Li H, Wang Y.

Chem Asian J. 2018 Jun 19. doi: 10.1002/asia.201800937. [Epub ahead of print]

PMID:
29923354
10.

Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management.

Desai K, Carroll I, Asch SM, Seto T, McDonald KM, Curtin C, Hernandez-Boussard T.

J Surg Res. 2018 Aug;228:160-169. doi: 10.1016/j.jss.2018.03.029. Epub 2018 Apr 11.

PMID:
29907207
11.

Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).

Atagi S, Mizusawa J, Ishikura S, Takahashi T, Okamoto H, Tanaka H, Goto K, Nakagawa K, Harada M, Takeda Y, Nogami N, Fujita Y, Kasai T, Kishi K, Sawa T, Takeda K, Tomii K, Satouchi M, Seto T, Ohe Y.

Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30100-1. doi: 10.1016/j.cllc.2018.04.018. [Epub ahead of print]

PMID:
29887243
12.

A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Kogure Y, Saka H, Takiguchi Y, Atagi S, Kurata T, Ebi N, Inoue A, Kubota K, Takenoyama M, Seto T, Kada A, Yamanaka T, Ando M, Yamamoto N, Gemma A, Ichinose Y.

Clin Lung Cancer. 2018 May 19. pii: S1525-7304(18)30110-4. doi: 10.1016/j.cllc.2018.05.005. [Epub ahead of print]

PMID:
29861395
13.

Mining Electronic Health Records to Extract Patient-Centered Outcomes Following Prostate Cancer Treatment.

Hernandez-Boussard T, Kourdis PD, Seto T, Ferrari M, Blayney DW, Rubin D, Brooks JD.

AMIA Annu Symp Proc. 2018 Apr 16;2017:876-882. eCollection 2017.

14.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

15.

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study.

Fujiwara Y, Takeda M, Yamamoto N, Nakagawa K, Nosaki K, Toyozawa R, Abe C, Shiga R, Nakamaru K, Seto T.

Oncotarget. 2018 May 4;9(34):23729-23737. doi: 10.18632/oncotarget.25263. eCollection 2018 May 4.

16.

Optimal Hematoma Volume Cut Points to Predict Functional Outcome After Basal Ganglia and Thalamic Hemorrhages.

Nakagawa K, King SL, Seto TB.

Front Neurol. 2018 May 1;9:291. doi: 10.3389/fneur.2018.00291. eCollection 2018.

17.

Is prophylactic cranial irradiation (PCI) needed in patients with extensive-stage small cell lung cancer showing complete response to first-line chemotherapy?

Nosaki K, Seto T, Shimokawa M, Takahashi T, Yamamoto N.

Radiother Oncol. 2018 Jun;127(3):344-348. doi: 10.1016/j.radonc.2018.04.010. Epub 2018 May 7. Review.

PMID:
29747871
18.

Disparities in Functional Outcome After Intracerebral Hemorrhage Among Asians and Pacific Islanders.

Nakagawa K, King SL, Seto TB, Mau MKLM.

Front Neurol. 2018 Mar 27;9:186. doi: 10.3389/fneur.2018.00186. eCollection 2018.

19.

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K.

J Clin Oncol. 2018 May 10;36(14):1405-1411. doi: 10.1200/JCO.2017.75.5587. Epub 2018 Mar 29.

PMID:
29596029
20.

Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population.

Obana A, Gohto Y, Moriyama T, Seto T, Sasano H, Okazaki S.

Jpn J Ophthalmol. 2018 Jul;62(4):473-480. doi: 10.1007/s10384-018-0588-3. Epub 2018 Mar 28.

PMID:
29594609
21.

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW.

Clin Cancer Res. 2018 Jun 15;24(12):2851-2858. doi: 10.1158/1078-0432.CCR-17-1323. Epub 2018 Mar 26.

PMID:
29581131
22.

Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.

Hida T, Kaji R, Satouchi M, Ikeda N, Horiike A, Nokihara H, Seto T, Kawakami T, Nakagawa S, Kubo T.

Clin Lung Cancer. 2018 Jul;19(4):e405-e415. doi: 10.1016/j.cllc.2018.01.004. Epub 2018 Feb 1.

23.

Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809.

Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Yoshiya K, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Saito H, Tsuchida M, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K.

Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000438. [Epub ahead of print]

PMID:
29521649
24.

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.

Kometani T, Sugio K, Osoegawa A, Seto T, Ichinose Y.

Thorac Cancer. 2018 May;9(5):563-570. doi: 10.1111/1759-7714.12616. Epub 2018 Mar 8.

25.

Valve-sparing aortic root replacement after double-switch operation for corrected transposition of the great arteries in a patient with ulcerative colitis.

Gomibuchi T, Okada K, Seto T, Okita Y.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):e175-e176. doi: 10.1016/j.jtcvs.2018.01.071. Epub 2018 Feb 10. No abstract available.

PMID:
29510935
26.

The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Seto T, Tagawa T, Takenoyama M, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.

PMID:
29500763
27.

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Okamoto I, Morita S, Tashiro N, Imamura F, Inoue A, Seto T, Yamamoto N, Ohe Y, Nakagawa K, Fukuoka M.

Lung Cancer. 2018 Mar;117:14-19. doi: 10.1016/j.lungcan.2018.01.005. Epub 2018 Jan 9.

28.

Reliability of a two-wavelength autofluorescence technique by Heidelberg Spectralis to measure macular pigment optical density in Asian subjects.

Obana A, Gellermann W, Gohto Y, Seto T, Sasano H, Tanito M, Okazaki S.

Exp Eye Res. 2018 Mar;168:100-106. doi: 10.1016/j.exer.2017.12.015. Epub 2018 Jan 20.

PMID:
29357284
29.

Increased Expression of Y-Box-Binding Protein-1 in Hind-Limb Muscles During Regeneration from Ischemic Injury in Mice.

Fuke M, Narita M, Wada Y, Seto T, Okada K, Nakayama J, Izumi H, Ito KI.

Tohoku J Exp Med. 2018 Jan;244(1):53-62. doi: 10.1620/tjem.244.53.

30.

Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.

Kojima A, Fukushima Y, Ito Y, Ding WG, Ueda R, Seto T, Kitagawa H, Matsuura H.

J Cardiovasc Pharmacol. 2018 Jan;71(1):10-18. doi: 10.1097/FJC.0000000000000538.

PMID:
29283926
31.

Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i.

Taira D, Sentell T, Albright C, Lansidell D, Nakagawa K, Seto T, Stevens JM.

Hawaii J Med Public Health. 2017 Nov;76(11):314-317.

32.

Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups.

Taira DA, Seto BK, Davis JW, Seto TB, Landsittel D, Sumida WK.

J Pharm Health Serv Res. 2017 Dec;8(4):247-253. doi: 10.1111/jphs.12193. Epub 2017 Aug 7.

PMID:
29151900
33.

Mutations in NSD1 and NFIX in Three Patients with Clinical Features of Sotos Syndrome and Malan Syndrome.

Lu Y, Chong PF, Kira R, Seto T, Ondo Y, Shimojima K, Yamamoto T.

J Pediatr Genet. 2017 Dec;6(4):234-237. doi: 10.1055/s-0037-1603194. Epub 2017 May 16.

PMID:
29142766
34.

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.

Seto T, Hirai F, Saka H, Kogure Y, Yoh K, Niho S, Fukase K, Shimada H, Sasai M, Fukino K.

Jpn J Clin Oncol. 2018 Jan 1;48(1):31-42. doi: 10.1093/jjco/hyx144.

PMID:
29136201
35.

Evidence of Carotenoid in Surgically Removed Lamellar Hole-Associated Epiretinal Proliferation.

Obana A, Sasano H, Okazaki S, Otsuki Y, Seto T, Gohto Y.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5157-5163. doi: 10.1167/iovs.17-22347.

PMID:
29049715
36.

Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results.

Kato T, Seto T, Nishio M, Goto K, Yamamoto N, Okamoto I, Tao L, Yu W, Khaznadar T, Tajima K, Shibata M, Seki A, Yamamoto N.

Drug Saf. 2018 Feb;41(2):229-237. doi: 10.1007/s40264-017-0596-0.

37.

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Yamaguchi M, Hirai F, Taguchi K, Toyozawa R, Edagawa M, Shimamatsu S, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Oct 4;3(1):108. doi: 10.1186/s40792-017-0382-3.

38.

Marked Decrease in Urgent Listing for Liver Transplantation Over Time: Evolution of Characteristics and Outcomes of Status-1 Liver Transplantation.

Wong LL, Truong HP, Seto T, Lacar L, Naugler WE.

Transplantation. 2018 Jan;102(1):e18-e25. doi: 10.1097/TP.0000000000001967.

PMID:
28968354
39.

Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocol.

Takeuchi S, Murayama T, Yoshimura K, Kawakami T, Takahara S, Imai Y, Kuribayashi Y, Nagase K, Goto K, Nishio M, Hasegawa Y, Satouchi M, Kiura K, Seto T, Yano S.

J Med Invest. 2017;64(3.4):317-320. doi: 10.2152/jmi.64.317.

40.

A novel CASK mutation identified in siblings exhibiting developmental disorders with/without microcephaly.

Seto T, Hamazaki T, Nishigaki S, Kudo S, Shintaku H, Ondo Y, Shimojima K, Yamamoto T.

Intractable Rare Dis Res. 2017 Aug;6(3):177-182. doi: 10.5582/irdr.2017.01031.

41.

Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report.

Edagawa M, Haratake N, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Kaneko K, Seto T, Takenoyama M, Ichinose Y.

J Thorac Dis. 2017 Aug;9(8):E689-E693. doi: 10.21037/jtd.2017.07.90.

42.

Surgical Repair of Cervical Aortic Arch With Brain Circulation Anomaly Through Clamshell Incision.

Gomibuchi T, Seto T, Yamamoto T, Nakahara K, Ohashi N, Ohtsu Y, Wada Y, Fukui D, Okada K.

Ann Thorac Surg. 2017 Sep;104(3):e235-e237. doi: 10.1016/j.athoracsur.2017.03.075.

PMID:
28838515
43.

Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test.

Satouchi M, Tanaka H, Yoshioka H, Shimokawaji T, Mizuno K, Takeda K, Yoshino I, Seto T, Kurata T, Tashiro N, Hagiwara K.

Lung Cancer. 2017 Sep;111:190-194. doi: 10.1016/j.lungcan.2017.07.015. Epub 2017 Jul 11.

44.

Cardio-Pulmonary Stethoscope: Clinical Validation With Heart Failure and Hemodialysis Patients.

Iskander MF, Seto TB, Perron RR, Lim E, Qazi F.

IEEE Trans Biomed Eng. 2018 May;65(5):1176-1180. doi: 10.1109/TBME.2017.2739695. Epub 2017 Aug 14.

45.

Toe grip strength in middle-aged individuals as a risk factor for falls.

Tsuyuguchi R, Kurose S, Seto T, Takao N, Tagashira S, Tsutsumi H, Otsuki S, Kimura Y.

J Sports Med Phys Fitness. 2018 Sep;58(9):1325-1330. doi: 10.23736/S0022-4707.17.07473-4. Epub 2017 Jul 24.

PMID:
28738667
46.

Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.

Hirai F, Edagawa M, Shimamatsu S, Toyozawa R, Toyokawa G, Nosaki K, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y.

Oncol Lett. 2017 Jul;14(1):306-312. doi: 10.3892/ol.2017.6118. Epub 2017 May 4.

47.

Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.

Kubaski F, Yabe H, Suzuki Y, Seto T, Hamazaki T, Mason RW, Xie L, Onsten TGH, Leistner-Segal S, Giugliani R, Dũng VC, Ngoc CTB, Yamaguchi S, Montaño AM, Orii KE, Fukao T, Shintaku H, Orii T, Tomatsu S.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1795-1803. doi: 10.1016/j.bbmt.2017.06.020. Epub 2017 Jul 1.

PMID:
28673849
48.

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Otsubo K, Nosaki K, Imamura CK, Ogata H, Fujita A, Sakata S, Hirai F, Toyokawa G, Iwama E, Harada T, Seto T, Takenoyama M, Ozeki T, Mushiroda T, Inada M, Kishimoto J, Tsuchihashi K, Suina K, Nagano O, Saya H, Nakanishi Y, Okamoto I.

Cancer Sci. 2017 Sep;108(9):1843-1849. doi: 10.1111/cas.13309. Epub 2017 Jul 26.

49.

Nontraumatic Proximal Ulnar Artery Pseudoaneurysm Mimicking a Soft Tissue Tumor in Image Modality.

Kehara H, Wada Y, Fukui D, Shingu K, Seto T, Okada K.

Ann Vasc Surg. 2018 Feb;47:279.e1-279.e5. doi: 10.1016/j.avsg.2017.06.036. Epub 2017 Jun 21.

PMID:
28647628
50.

Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011).

Sekine I, Harada H, Yamamoto N, Wakabayashi M, Murakami H, Goto K, Nogami N, Seto T, Oshita F, Okamoto H, Tanaka H, Tamura T, Ishikura S, Ohe Y.

Lung Cancer. 2017 Jun;108:232-237. doi: 10.1016/j.lungcan.2017.04.002. Epub 2017 Apr 4.

PMID:
28625642

Supplemental Content

Support Center